Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $7.92 USD
Change Today +0.25 / 3.26%
Volume 307.6K
NWBO On Other Exchanges
As of 8:10 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Linda F. Powers J.D.

Chairperson, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer,Northwest Biotherapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 72 board members in 5 different organizations across 6 different industries.

See Board Relationships
As of Fiscal Year 2014


Ms. Linda F. Powers, J.D., has been the Chief Executive Officer of Northwest Biotherapeutics, Inc. since June 08, 2011 and serves as its President, Chief Financial Officer and Accounting Officer. Ms. Powers serves as Managing Director of Toucan Capital Corp. and Toucan Capital Fund II, L.P. She is a Co-Founder of Toucan Capital Corp. and Toucan Capital Fund II, L.P. She has more than 25 years of experience in the fields of venture capital, public-private partnerships, ...

Read Full Background

Corporate Headquarters*

4800 Montgomery Lane
Bethesda, Maryland 20814

United States

Phone: 240-497-9024
Fax: --

Board Members Memberships*

Member of Board of Trustees
Chairperson, Chief Executive Officer, President, Chief Financial Officer and Principal Accounting Officer


Princeton University
Harvard Law School
Woodrow Wilson School of Public and International Affairs

Other Affiliations*

Annual Compensation*

Total Annual Compensation$500,000

Stock Options*

Exercisable Options592,500
Unexercisable Options296,250
Total Number of Options888,750

Total Compensation*

Total Annual Cash Compensation$500,000
Total Short Term Compensation$500,000
Total Calculated Compensation$500,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NWBO:US $7.92 USD +0.25


Martin M. McGlynn Chief Executive Officer, Director, Member of Strategic Transactions Committee, Chief Executive Officer of Stemcells California Inc and President of Stemcells California Inc
StemCells Inc.
David J. Mazzo B.A (Hons), B.Sc. (Hons.), M.Sc., Ph.D.Chief Executive Officer and Director
Caladrius Biosciences, Inc.
Weidong Yin Chairman, Chief Executive Officer, President, Managing Director, Secretary, Chairman of Sinovac Hong Kong, Chairman of Tangshan Yian, Chairman of Sinovac Dalian and Director of Sinovac Biotech Co
Sinovac Biotech Ltd.
Neil K. Warma Chief Executive Officer, President and Director
Opexa Therapeutics, Inc.
Zhilin Li Chairman, Chief Executive Officer, President and Interim Chief Financial Officer
China Pharma Holdings, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NORTHWEST BIOTHERAPEUTICS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at